352 related articles for article (PubMed ID: 29734463)
21. Association between triglyceride glucose-body mass index and non-alcoholic fatty liver disease in the non-obese Chinese population with normal blood lipid levels: a secondary analysis based on a prospective cohort study.
Li Y; Zheng R; Li J; Feng S; Wang L; Huang Z
Lipids Health Dis; 2020 Oct; 19(1):229. PubMed ID: 33109219
[TBL] [Abstract][Full Text] [Related]
22. Diabetes Mellitus Heightens the Risk of Hepatocellular Carcinoma Except in Patients With Hepatitis C Cirrhosis.
Yang JD; Mohamed HA; Cvinar JL; Gores GJ; Roberts LR; Kim WR
Am J Gastroenterol; 2016 Nov; 111(11):1573-1580. PubMed ID: 27527741
[TBL] [Abstract][Full Text] [Related]
23. Association of nonalcoholic fatty liver disease and liver cancer.
Schulz PO; Ferreira FG; Nascimento Mde F; Vieira A; Ribeiro MA; David AI; Szutan LA
World J Gastroenterol; 2015 Jan; 21(3):913-8. PubMed ID: 25624725
[TBL] [Abstract][Full Text] [Related]
24. The Effects of Hepatic Steatosis on the Natural History of HBV Infection.
Suliman I; Abdelgelil N; Kassamali F; Hassanein TI
Clin Liver Dis; 2019 Aug; 23(3):433-450. PubMed ID: 31266618
[TBL] [Abstract][Full Text] [Related]
25. Nonalcoholic fatty liver disease progression rates to cirrhosis and progression of cirrhosis to decompensation and mortality: a real world analysis of Medicare data.
Loomba R; Wong R; Fraysse J; Shreay S; Li S; Harrison S; Gordon SC
Aliment Pharmacol Ther; 2020 Jun; 51(11):1149-1159. PubMed ID: 32372515
[TBL] [Abstract][Full Text] [Related]
26. Epidemiology, disease burden and outcomes of cirrhosis in a large secondary care hospital in South Auckland, New Zealand.
Hsiang JC; Bai WW; Raos Z; Stableforth W; Upton A; Selvaratnam S; Gane EJ; Gerred SJ
Intern Med J; 2015 Feb; 45(2):160-9. PubMed ID: 25371019
[TBL] [Abstract][Full Text] [Related]
27. Intake of the different types of dairy products, genetic predisposition, and the risks of nonalcoholic fatty liver disease and cirrhosis: a prospective cohort study.
Wu H; Li S; Chen L; Xia Y; Tan X
Food Funct; 2024 May; 15(9):5050-5062. PubMed ID: 38656457
[No Abstract] [Full Text] [Related]
28. Hepatitis B virus infection and risk of non-alcoholic fatty liver disease: A population-based cohort study.
Zhu L; Jiang J; Zhai X; Baecker A; Peng H; Qian J; Zhou M; Song C; Zhou Y; Xu J; Liu H; Hang D; Hu Z; Shen H; Zhang ZF; Zhu F
Liver Int; 2019 Jan; 39(1):70-80. PubMed ID: 30025200
[TBL] [Abstract][Full Text] [Related]
29. A prospective study on the prevalence of NAFLD, advanced fibrosis, cirrhosis and hepatocellular carcinoma in people with type 2 diabetes.
Ajmera V; Cepin S; Tesfai K; Hofflich H; Cadman K; Lopez S; Madamba E; Bettencourt R; Richards L; Behling C; Sirlin CB; Loomba R
J Hepatol; 2023 Mar; 78(3):471-478. PubMed ID: 36410554
[TBL] [Abstract][Full Text] [Related]
30. Non-alcoholic fatty liver disease predicts type 2 diabetes mellitus, but not prediabetes, in Xi'an, China: a five-year cohort study.
Ming J; Xu S; Gao B; Liu G; Ji Y; Yang F; Jia Y; Fang Y; Ji Q
Liver Int; 2015 Nov; 35(11):2401-7. PubMed ID: 25879672
[TBL] [Abstract][Full Text] [Related]
31. Diet and Risk of Non-Alcoholic Fatty Liver Disease, Cirrhosis, and Liver Cancer: A Large Prospective Cohort Study in UK Biobank.
Guo W; Ge X; Lu J; Xu X; Gao J; Wang Q; Song C; Zhang Q; Yu C
Nutrients; 2022 Dec; 14(24):. PubMed ID: 36558494
[TBL] [Abstract][Full Text] [Related]
32. Clinical characteristics of non-alcoholic fatty liver disease in Chinese adult hypopituitary patients.
Yuan XX; Zhu HJ; Pan H; Chen S; Liu ZY; Li Y; Wang LJ; Lu L; Yang HB; Gong FY
World J Gastroenterol; 2019 Apr; 25(14):1741-1752. PubMed ID: 31011258
[TBL] [Abstract][Full Text] [Related]
33. Cancer Risk in Patients With Biopsy-Confirmed Nonalcoholic Fatty Liver Disease: A Population-Based Cohort Study.
Simon TG; Roelstraete B; Sharma R; Khalili H; Hagström H; Ludvigsson JF
Hepatology; 2021 Nov; 74(5):2410-2423. PubMed ID: 33811766
[TBL] [Abstract][Full Text] [Related]
34. Alcoholic liver disease presents at advanced stage and progresses faster compared to non-alcoholic fatty liver diseas.
Shoreibah M; Raff E; Bloomer J; Kakati D; Rasheed K; Kuo YF; Singal AK
Ann Hepatol; 2016; 15(2):183-9. PubMed ID: 26845595
[TBL] [Abstract][Full Text] [Related]
35. Clinical, Epidemiological and Histopathological Aspects in Patients with Hepatocellular Carcinoma Undergoing Liver Transplantation.
Tunissiolli NM; Castanhole-Nunes MMU; Pavarino ÉC; da Silva RF; da Silva RCMA; Maria Goloni-Bertollo E
Asian Pac J Cancer Prev; 2018 Oct; 19(10):2795-2802. PubMed ID: 30360608
[TBL] [Abstract][Full Text] [Related]
36. Differentiation of clinical patterns and survival outcomes of hepatocellular carcinoma on hepatitis B and nonalcoholic fatty liver disease.
Lin BZ; Lin TJ; Lin CL; Liao LY; Chang TA; Lu BJ; Chen KY
J Chin Med Assoc; 2021 Jun; 84(6):606-613. PubMed ID: 33871391
[TBL] [Abstract][Full Text] [Related]
37. Nonalcoholic Fatty Liver Disease and the Development of Metabolic Comorbid Conditions in Patients With Human Immunodeficiency Virus Infection.
Krahn T; Martel M; Sapir-Pichhadze R; Kronfli N; Falutz J; Guaraldi G; Lebouche B; Klein MB; Wong P; Deschenes M; Ghali P; Sebastiani G
J Infect Dis; 2020 Aug; 222(5):787-797. PubMed ID: 32249283
[TBL] [Abstract][Full Text] [Related]
38. High NAFLD fibrosis score in non-alcoholic fatty liver disease as a predictor of carotid plaque development: a retrospective cohort study based on regular health check-up data in China.
Yu X; Chen C; Guo Y; Tong Y; Zhao Y; Wu L; Sun X; Wu X; Song Z
Ann Med; 2021 Dec; 53(1):1621-1631. PubMed ID: 34498502
[TBL] [Abstract][Full Text] [Related]
39. Models estimating risk of hepatocellular carcinoma in patients with alcohol or NAFLD-related cirrhosis for risk stratification.
Ioannou GN; Green P; Kerr KF; Berry K
J Hepatol; 2019 Sep; 71(3):523-533. PubMed ID: 31145929
[TBL] [Abstract][Full Text] [Related]
40. Association between the lean nonalcoholic fatty liver disease and risk of incident type 2 diabetes in a healthy population of Northwest China: a retrospective cohort study with a 2-year follow-up period.
Li N; Xang W; Wu S; Li D; Chang M; Xie C; Zhang MY; Tan H
Front Endocrinol (Lausanne); 2023; 14():1173757. PubMed ID: 37435491
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]